Report overview
This report contains market size and forecasts of Axial Spondyloarthritis Drugs in global, including the following market information:
Global Axial Spondyloarthritis Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Axial Spondyloarthritis Drugs Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Axial Spondyloarthritis Drugs companies in 2021 (%)
The global Axial Spondyloarthritis Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Certolizumab Pegol Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Axial Spondyloarthritis Drugs include AstraZeneca Plc, Eli Lilly and Company, Johnson & Johnson, Novartis AG, Panacea Biotec Ltd, Sandoz International GmbH, Sun Pharma Advanced Research Company Ltd and UCB SA, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Axial Spondyloarthritis Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Axial Spondyloarthritis Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Axial Spondyloarthritis Drugs Market Segment Percentages, by Type, 2021 (%)
Certolizumab Pegol
Etanercept Biosimilar
Ixekizumab
Secukinumab
Others
Global Axial Spondyloarthritis Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Axial Spondyloarthritis Drugs Market Segment Percentages, by Application, 2021 (%)
Clinic
Hospital
Home Care
Global Axial Spondyloarthritis Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Axial Spondyloarthritis Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Axial Spondyloarthritis Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Axial Spondyloarthritis Drugs revenues share in global market, 2021 (%)
Key companies Axial Spondyloarthritis Drugs sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Axial Spondyloarthritis Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca Plc
Eli Lilly and Company
Johnson & Johnson
Novartis AG
Panacea Biotec Ltd
Sandoz International GmbH
Sun Pharma Advanced Research Company Ltd
UCB SA
